Insulin resistance can be detected through several blood tests, ranging from a simple fasting blood draw to more complex glucose challenges. The most practical starting point is a fasting insulin and glucose test, which your doctor can use to calculate a score called HOMA-IR. A HOMA-IR of 2.5 or higher is the threshold used by major U.S. health surveys to flag insulin resistance.
Fasting Insulin and HOMA-IR
The most common way to screen for insulin resistance in a clinical setting is a fasting blood test that measures both your insulin and glucose levels. From those two numbers, your doctor calculates a HOMA-IR score by multiplying fasting insulin (in microunits per mL) by fasting glucose (in mg/dL) and dividing by 405. The result tells you how hard your body is working to keep blood sugar in check.
There’s no single universally agreed-upon cutoff, but values between 2.0 and 3.0 are commonly used in U.S. clinical and research settings. The National Health and Nutrition Examination Survey (NHANES) uses 2.5 as its threshold. For context, a large study of U.S. adults without diabetes found a median HOMA-IR of 2.2 and a mean of 2.8. In normal-weight adolescents, the average was 2.3, while adolescents with obesity averaged 4.9. In Asian populations, cutoffs tend to be lower, typically ranging from 1.4 to 2.5.
You’ll need to fast for 8 to 12 hours before the blood draw. If you take biotin supplements (vitamin B7), stop them at least a day beforehand, as biotin can interfere with certain lab assays.
The Triglyceride-to-HDL Ratio
If you already have a recent lipid panel, you can get a rough estimate of insulin resistance without any additional testing. Divide your triglycerides by your HDL cholesterol. When both are measured in mg/dL, a ratio above 3.8 in White European men or above 2.0 in White European women suggests insulin resistance. In South Asian men and women, lower cutoffs apply: about 2.8 and 2.5, respectively.
This ratio isn’t a formal diagnostic test, but it correlates well enough with insulin resistance that many clinicians use it as a quick screening tool, especially when fasting insulin levels weren’t ordered.
The Oral Glucose Tolerance Test
An oral glucose tolerance test (OGTT) goes a step further than a fasting test by watching how your body handles a standardized sugar load. You drink 75 grams of glucose solution, and your blood is drawn at intervals, typically at the start and again at 30, 60, 90, and 120 minutes. The test is most commonly used to diagnose prediabetes and diabetes based on the glucose readings alone, but when insulin is measured at each time point alongside glucose, it reveals much more about how your body is responding.
From the OGTT data, clinicians can calculate the Matsuda Index, which captures whole-body insulin sensitivity by factoring in both fasting and average glucose and insulin values across the test. A low Matsuda score points to insulin resistance. Another useful calculation is the Insulinogenic Index, which looks at how much insulin your pancreas releases in the first 30 minutes relative to the glucose spike. This helps distinguish between someone whose pancreas is compensating heavily (a sign of resistance) and someone whose insulin response is sluggish (a sign of beta-cell dysfunction). The OGTT can’t cleanly separate first-phase from second-phase insulin release the way more specialized tests can, but it remains the most widely used clinical test for evaluating glucose handling.
The Gold Standard: The Clamp Test
The most precise way to measure insulin resistance is the hyperinsulinemic-euglycemic clamp, though it’s almost exclusively used in research settings. During the procedure, insulin is infused intravenously at a constant rate while glucose is simultaneously dripped in and adjusted every few minutes to keep blood sugar perfectly stable. The key measurement is how much glucose has to be infused to prevent blood sugar from dropping. A person with good insulin sensitivity needs a lot of glucose to counterbalance the insulin, while someone with insulin resistance needs very little because their cells aren’t responding well to the insulin signal.
By adding a glucose tracer (a tagged version of glucose), researchers can also separate liver-driven insulin resistance from muscle-driven resistance. The liver primarily controls glucose production, so measuring how much that production drops during insulin infusion reveals hepatic insulin sensitivity. Muscle tissue, on the other hand, is the main site of glucose uptake, so the increase in glucose clearance reflects peripheral sensitivity. No other test cleanly separates these two components. The clamp requires an IV, frequent blood sampling, and several hours of monitoring, which is why it stays in the lab rather than the clinic.
The Lipoprotein Insulin Resistance Score
A newer option called the LP-IR score uses a specialized type of blood test based on nuclear magnetic resonance (NMR) spectroscopy. Instead of measuring insulin directly, it analyzes the sizes and concentrations of your lipoprotein particles, specifically your VLDL, LDL, and HDL. Insulin resistance shifts these particles in predictable ways: VLDL particles get larger, HDL particles get smaller, and small dense LDL particles increase. The test combines these six measurements into a single score from 0 (most insulin sensitive) to 100 (most insulin resistant).
The LP-IR score sidesteps a real limitation of insulin-based tests. Insulin assays are not standardized across laboratories, meaning the same blood sample can produce different insulin readings depending on which lab processes it. There’s also natural variability because insulin is released in pulses, so a single fasting sample can be a somewhat noisy measurement. The LP-IR score avoids both of these problems. It performs comparably to fasting insulin-based indices in predicting insulin resistance and is available through some commercial labs, though it’s not yet part of routine screening.
Physical Signs Worth Checking
Before any blood test, your body may already be showing signs of insulin resistance. Waist-to-hip ratio is one of the simplest physical markers. Measure the narrowest part of your waist and the widest part of your hips, then divide waist by hip. A ratio above 1.0 for men or above 0.8 for women indicates abdominal obesity, which is strongly linked to insulin resistance. Waist circumference alone is also useful: above 40 inches in men or 35 inches in women raises risk.
Dark, velvety patches of skin in the folds of your neck, armpits, or groin, a condition called acanthosis nigricans, are another visible marker. These patches develop because excess insulin in the blood stimulates skin cell growth. Skin tags in similar locations are associated with insulin resistance as well. Neither of these is definitive on its own, but combined with a high waist-to-hip ratio and other risk factors, they give a clinician good reason to order blood work.
Which Test to Ask For
For most people, a fasting insulin and fasting glucose panel is the right place to start. It’s inexpensive, widely available, and gives you a HOMA-IR score that’s clinically meaningful. If your doctor orders a standard metabolic panel but doesn’t include fasting insulin, you may need to specifically request it, as fasting glucose alone can stay normal for years while insulin levels climb to compensate.
If fasting results are borderline or you have risk factors like a strong family history of type 2 diabetes, polycystic ovary syndrome, or significant abdominal weight, an oral glucose tolerance test with insulin levels measured at each time point provides a more dynamic picture. The triglyceride-to-HDL ratio from a routine lipid panel is worth calculating regardless, since you may already have the numbers on hand. The LP-IR score and the clamp test are specialized tools, one increasingly available through commercial labs and the other reserved for research, that fill in details most people won’t need for a clinical decision.